Increasing LRP4 diminishes neuromuscular deficits in a mouse model of Duchenne muscular dystrophy

Autor: Hongyang Jing, Tiankun Hui, Peng Chen, Shunqi Wang, Daojun Hong, Min Yan, Tian Zhou, Xia Dong, Suqi Zou, Ziyang Liu, Erkang Fei, Dongyan Ren, Xinsheng Lai
Jazyk: angličtina
Rok vydání: 2021
Předmět:
0301 basic medicine
musculoskeletal diseases
AcademicSubjects/SCI01140
congenital
hereditary
and neonatal diseases and abnormalities

China
Neuromuscular disease
Duchenne muscular dystrophy
Muscle Fibers
Skeletal

Neuromuscular transmission
Neuromuscular Junction
Mice
Transgenic

Biology
Synaptic Transmission
Neuromuscular junction
Dystrophin-associated glycoprotein complex
Dystrophin
03 medical and health sciences
Mice
0302 clinical medicine
Glycoprotein complex
Genetics
medicine
Animals
Humans
Regeneration
Muscle Strength
Muscle
Skeletal

Molecular Biology
Genetics (clinical)
LDL-Receptor Related Proteins
Autoantibodies
Denervation
Agrin
General Medicine
medicine.disease
musculoskeletal system
Cell biology
Muscular Dystrophy
Duchenne

Disease Models
Animal

030104 developmental biology
medicine.anatomical_structure
nervous system
Mice
Inbred mdx

General Article
030217 neurology & neurosurgery
Muscle Contraction
Zdroj: Human Molecular Genetics
ISSN: 1460-2083
0964-6906
Popis: Duchenne muscular dystrophy (DMD) is an X-linked neuromuscular disease characterized by progressive wasting of skeletal muscles. The neuromuscular junction (NMJ) is a synapse between motor neurons and skeletal muscle fibers, critical for the control of muscle contraction. The NMJ decline is observed in DMD patients, but the mechanism is unclear. LRP4 serves as a receptor for agrin, a proteoglycan secreted by motor neurons to induce NMJ, and plays a critical role in NMJ formation and maintenance. Interestingly, we found that protein levels of LRP4 were reduced both in muscles of the DMD patients and DMD model mdx mice. We explored whether increasing LRP4 is beneficial for DMD and crossed muscle-specific LRP4 transgenic mice with mdx mice (mdx; HSA-LRP4). The LRP4 transgene increased muscle strength, together with improved neuromuscular transmission in mdx mice. Furthermore, we found the LRP4 expression mitigated NMJ fragments and denervation in mdx mice. Mechanically, we showed that overexpression of LRP4 increased the activity of MuSK and expression of dystrophin-associated glycoprotein complex proteins in the mdx mice. Overall, our findings suggest that increasing LRP4 improves both function and structure of NMJ in the mdx mice and Agrin signaling might serve as a new therapeutic strategy in DMD.
Databáze: OpenAIRE